Although the mechanisms of complement activation in APS are still poorly understood, the regulation of complement by means of the enhancement of C3/C3b degradation [30] and the activation of the classical complement pathway [31] induced by aPLA have been proposed. This evidence concerns the gene C3 and autoimmune polyendocrinopathy.